Michael Bscheider

Michael Bscheider is a Principal Scientist in Investigative & Immunosafety at Roche pRED, where they focus on bridging exploratory science with clinical applications. They have extensive experience in human in-vitro models and multi-omics, contributing to drug development. Previously, they held postdoctoral positions at Stanford University and Technische Universität München, and they completed their MD thesis at LMU - Ludwig-Maximilians-Universität München. Michael also served as a Senior Scientist and Section Head in various capacities at Roche before taking on their current role. They are currently engaged in subintern rotations at Harvard Medical School and the University of Lausanne.